Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
medcolombia.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Valuation

$0000 

About MED Colombia

MED Colombia cultivates cannabis and produces cannabis ol extracts, along with cannabis genetics.

MED Colombia Headquarter Location

Address Calle 124 #7-35 Office 701

Bogota,

Colombia

+57 1 5111947

Latest MED Colombia News

MedReleaf acquires MED Colombia

Jul 25, 2018

MedReleaf acquires MED Colombia MedReleaf ( OTCPK:MEDFF ) has acquired MED Colombia SAS for a total consideration of €2.75M in cash. MED Colombia has permit (in Colombia) to cultivate cannabis and produce cannabis oil extracts, along with a library of cannabis genetics. The acquisition provides MedReleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain as well as the domestic Colombian medical cannabis market.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MED Colombia

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MED Colombia is included in 1 Expert Collection, including Cannabis.

C

Cannabis

3,519 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.